The Food and Drug Administration (FDA) announced it was taking unprecedented steps to encourage drug companies to develop over-the-counter (OTC) versions of the overdose antidote naloxone in an effort to increase access and cut costs for consumers in hopes of reducing opioid deaths. Read More.
Researchers are reporting a link between doctor-targeted marketing of opioid products and the increase in US. deaths from overdoses. Read More.
Some wonder if people with opioid addiction are using their pet’s prescriptions to feed their own addictions instead. In the last 10 years, there has been a 41% increase in opioid prescriptions for pets. Read More.
Few medical facilities around the U.S. offer proper medication to treat opioid use disorder, even as the country continues to grapple with a growing epidemic, a study says. Read More.
Changes could be coming regarding the way prescription opioids are handed out. Many states restrict the supply doctors prescribe, from three to 14 days, and Minnesota may be moving in that direction. Read More.
Buprenorphine Prescribing Restrictions Threaten Progress in the Opioid Epidemic – Medscape – Jan. 14, 2019
The American opioid epidemic is like no other drug crisis in history, spanning all ages and socioeconomic classes. We emergency physicians have unique access to patients with opioid use disorder, yet few of us are able to treat patients after an opioid-related overdose with medications such as buprenorphine in the emergency department. Read More.
Over the past 20 years, the opioid overdose rate has skyrocketed among women between 30 and 64 years old, according to new analysis released Thursday by the United States Centers for Disease Control and Prevention (CDC). Read More.
Minnesota Dental Association Releases Opioid Support Materials for Dentists and Patients – PRNewswire – Jan. 7, 2019
The Minnesota Dental Association (MDA) has published a new brochure on pain management and the dangers of opioid use. Read More.
Hy-Vee no longer will allow its pharmacies to refill prescriptions of certain controlled substances more than 72 hours early without a doctor’s authorization. Read More.
Women’s Health Research at Yale is calling on a government committee to revise its report on a coordinated response to the opioid epidemic so that it reflects the unique needs of women. Read More.